90 related articles for article (PubMed ID: 16113031)
1. Toward an understanding of decision making on complementary and alternative medicine use in poorer countries: the case of cancer care in Pakistan.
Tovey P; Chatwin J; Ahmad S
Integr Cancer Ther; 2005 Sep; 4(3):236-41. PubMed ID: 16113031
[TBL] [Abstract][Full Text] [Related]
2. Use of traditional medicine and globalized complementary and alternative medicine among low-income cancer service users in Brazil.
Tovey P; de Barros NF; Hoehne EL; Carvalheira JB
Integr Cancer Ther; 2006 Sep; 5(3):232-5. PubMed ID: 16880428
[TBL] [Abstract][Full Text] [Related]
3. Patient assessment of effectiveness and satisfaction with traditional medicine, globalized complementary and alternative medicines, and allopathic medicines for cancer in Pakistan.
Tovey P; Broom A; Chatwin J; Hafeez M; Ahmad S
Integr Cancer Ther; 2005 Sep; 4(3):242-8. PubMed ID: 16113032
[TBL] [Abstract][Full Text] [Related]
4. Assessing the role of evidence in patients' evaluation of complementary therapies: a quality study.
Verhoef MJ; Mulkins A; Carlson LE; Hilsden RJ; Kania A
Integr Cancer Ther; 2007 Dec; 6(4):345-53. PubMed ID: 18048882
[TBL] [Abstract][Full Text] [Related]
5. Challenges to complementary and alternative medical research: focal issues influencing integration into a cancer care model.
Giordano J; Engebretson J; Garcia MK
Integr Cancer Ther; 2005 Sep; 4(3):210-8. PubMed ID: 16113028
[TBL] [Abstract][Full Text] [Related]
6. Complementary and alternative medicine use in lung cancer patients in eight European countries.
Molassiotis A; Panteli V; Patiraki E; Ozden G; Platin N; Madsen E; Browall M; Fernandez-Ortega P; Pud D; Margulies A
Complement Ther Clin Pract; 2006 Feb; 12(1):34-9. PubMed ID: 16401528
[TBL] [Abstract][Full Text] [Related]
7. A literature review of complementary and alternative medicine use by colorectal cancer patients.
Sewitch MJ; Rajput Y
Complement Ther Clin Pract; 2010 Feb; 16(1):52-6. PubMed ID: 20129411
[TBL] [Abstract][Full Text] [Related]
8. Use of traditional, complementary and allopathic medicines in Pakistan by cancer patients.
Tovey PA; Broom AF; Chatwin J; Ahmad S; Hafeez M
Rural Remote Health; 2005; 5(4):447. PubMed ID: 16351496
[TBL] [Abstract][Full Text] [Related]
9. Complementary and alternative medicine during cancer treatment: beyond innocence.
Tascilar M; de Jong FA; Verweij J; Mathijssen RH
Oncologist; 2006; 11(7):732-41. PubMed ID: 16880232
[TBL] [Abstract][Full Text] [Related]
10. Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.
Hlubocky FJ; Ratain MJ; Wen M; Daugherty CK
J Clin Oncol; 2007 Feb; 25(5):548-54. PubMed ID: 17290064
[TBL] [Abstract][Full Text] [Related]
11. Complementary and alternative care within cancer care.
Krasuska ME; Stanisławek A; Mazurkiewicz M
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):418-24. PubMed ID: 15323229
[TBL] [Abstract][Full Text] [Related]
12. The influence of significant others in complementary and alternative medicine decisions by cancer patients.
Ohlén J; Balneaves LG; Bottorff JL; Brazier AS
Soc Sci Med; 2006 Sep; 63(6):1625-36. PubMed ID: 16725245
[TBL] [Abstract][Full Text] [Related]
13. Using qualitative interviews in CAM research: a guide to study design, data collection and data analysis.
Broom A
Complement Ther Med; 2005 Mar; 13(1):65-73. PubMed ID: 15907681
[TBL] [Abstract][Full Text] [Related]
14. Cancer patients' negotiation of therapeutic options in Pakistan.
Tovey P; Broom A
Qual Health Res; 2007 May; 17(5):652-62. PubMed ID: 17478647
[TBL] [Abstract][Full Text] [Related]
15. What is an exceptional cancer trajectory?: Multiple stakeholder perspectives on cancer trajectories in relation to complementary and alternative medicine use.
Hök J; Forss A; Falkenberg T; Tishelman C
Integr Cancer Ther; 2009 Jun; 8(2):153-63. PubMed ID: 19679624
[TBL] [Abstract][Full Text] [Related]
16. Pediatric use of complementary and alternative medicine: legal, ethical, and clinical issues in decision-making.
Gilmour J; Harrison C; Cohen MH; Vohra S
Pediatrics; 2011 Nov; 128 Suppl 4():S149-54. PubMed ID: 22045856
[TBL] [Abstract][Full Text] [Related]
17. Complementary and alternative medicine use in asthma: who is using what?
Slader CA; Reddel HK; Jenkins CR; Armour CL; Bosnic-Anticevich SZ
Respirology; 2006 Jul; 11(4):373-87. PubMed ID: 16771907
[TBL] [Abstract][Full Text] [Related]
18. Use of antidepressants and complementary and alternative medicine among outpatients with depression in Taiwan.
Hsu MC; Moyle W; Creedy D; Venturato L; Ouyang WC; Tsay SL
Arch Psychiatr Nurs; 2009 Feb; 23(1):75-85. PubMed ID: 19216991
[TBL] [Abstract][Full Text] [Related]
19. Complementary and alternative medicine use in colorectal cancer patients in seven European countries.
Molassiotis A; Fernandez-Ortega P; Pud D; Ozden G; Platin N; Hummerston S; Scott JA; Panteli V; Gudmundsdottir G; Selvekerova S; Patiraki E; Kearney N
Complement Ther Med; 2005 Dec; 13(4):251-7. PubMed ID: 16338195
[TBL] [Abstract][Full Text] [Related]
20. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
